Studies of White Blood Cells Derived From HHT Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00230633 |
Recruitment Status
: Unknown
Verified August 2008 by Imperial College London.
Recruitment status was: Recruiting
First Posted
: October 3, 2005
Last Update Posted
: August 13, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Telangiectasia, Hereditary Hemorrhagic |
Study Type : | Observational |
Estimated Enrollment : | 200 participants |
Time Perspective: | Prospective |
Official Title: | Studies of White Blood Cells Derived From HHT Patients |
Study Start Date : | April 2002 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with HHT, and family members
Exclusion Criteria:
- Unable to provide informed consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00230633
Contact: Claire L Shovlin | 0208 383 1000 | c.shovlin@imperial.ac.uk |
United Kingdom | |
Imperial College Hammersmith Campus | Recruiting |
London, United Kingdom, W12 0NN | |
Contact: Claire L Shovlin 0208 383 1000 c.shovlin@imperial.ac.uk | |
Principal Investigator: Claire L Shovlin |
Principal Investigator: | Claire L Shovlin | Imperial College London |
ClinicalTrials.gov Identifier: | NCT00230633 History of Changes |
Other Study ID Numbers: |
IC/CLS3 |
First Posted: | October 3, 2005 Key Record Dates |
Last Update Posted: | August 13, 2008 |
Last Verified: | August 2008 |
Additional relevant MeSH terms:
Telangiectasis Telangiectasia, Hereditary Hemorrhagic Vascular Diseases Cardiovascular Diseases Hemostatic Disorders |
Hemorrhagic Disorders Hematologic Diseases Vascular Malformations Cardiovascular Abnormalities Congenital Abnormalities |